A Study to Assess the Safety and Efficacy of Adalimumab When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis

NCT00448383 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
6610
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott